Development of CTIM-76, a highly specific Claudin 6 bispecific antibody for treatment of ovarian cancer

Publications

Apr 20

Written By Martin Lehr

2023_AACR_MPS CLDN6 bispecifics1024_1.jpg

Martin Lehr

CTIM-76, a Highly Specific Claudin 6 Antibody

Atomic-level Specificity of Claudin 6 Monoclonal Antibodies Isolated for Treating Solid Tumors